Microwants insulin separation solutions — reversed-phase preparative purification, charge variant and aggregate control, related-substance analysis and industrial scale-up for recombinant human insulin and insulin analogues. Content in preparation.
This page is in preparation. The four modules below form the chapter skeleton; anchors are fixed, so adding selection parameters, process routes and application conditions later will not break existing links. For specific products and scales, contact our technical team.
The main purification step for recombinant insulin and its analogues. Loading, organic gradient and column temperature strongly affect the separation of related substances such as deamidation products and disulfide isomers, and must be calibrated batch by batch against the crude. Content in preparation.
Deamidation products have isoelectric points close to the main component, so ion exchange offers selectivity orthogonal to reversed-phase; dimers and higher aggregates are usually confirmed by size exclusion. Content in preparation.
Load conversion from analytical to industrial preparative columns, packing process and bed stability, and the effect of solvent and buffer salt consumption on unit cost. Content in preparation.
Content in preparation; contact us with your product and scale for selection advice
If your application is unusual, contact our technical team directly — selection consulting is free of charge.